COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey

Affiliations

¹ Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
² Department of Medicine, Allergy Unit and Asthma Center, University of Verona and Verona University Hospital, Verona, Italy.
³ Respiratory Pathophysiology Unit, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Italy.
⁴ Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy.
⁵ Department of Medical Specialties, Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.
⁶ Department of Medicine, Respiratory Medicine Unit and Section of Internal Medicine, University of Verona and Verona University Hospital, Verona, Italy.
⁷ Allergy and respiratory diseases, DIMI Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy.
⁸ Departmental Unit of Allergology, Istituto Ospedaliero "Fondazione Poliambulanza", Brescia, Italy.
⁹ Immunology and Cell Therapy Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
¹⁰ Allergology Unit - Occupational Medicine, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.
¹¹ UOC Pneumologia Cittadella, Euganea, Italy.

Multicenter Study

Andrea Matucci et al. Allergy. 2021 Mar.

. 2021 Mar;76(3):871-874.

doi: 10.1111/all.14516. Epub 2020 Aug 11.

¹ Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
² Department of Medicine, Allergy Unit and Asthma Center, University of Verona and Verona University Hospital, Verona, Italy.
³ Respiratory Pathophysiology Unit, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Italy.
⁴ Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy.
⁵ Department of Medical Specialties, Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.
⁶ Department of Medicine, Respiratory Medicine Unit and Section of Internal Medicine, University of Verona and Verona University Hospital, Verona, Italy.
⁷ Allergy and respiratory diseases, DIMI Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy.
⁸ Departmental Unit of Allergology, Istituto Ospedaliero "Fondazione Poliambulanza", Brescia, Italy.
⁹ Immunology and Cell Therapy Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
¹⁰ Allergology Unit - Occupational Medicine, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.
¹¹ UOC Pneumologia Cittadella, Euganea, Italy.

No abstract available

Keywords: asthma; biologics; infections; virus.

References

1. Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria in acute asthma exacerbations-a GA2 LEN-DARE systematic review. Allergy. 2011;66:458-468.
1. Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev Microbiol. 2012;10:459-471.
1. Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203.
1. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patietns infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-1741. https://doi.org/10.1111/all.14238
1. Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574.